Zila, a TOLMAR Company, Launches ViziLite(R) Plus Angled Exam Mirror to Aid in the Early Detection of Oral Cancer
FORT COLLINS, Colo., June 28 /PRNewswire/ -- Zila, leader in the prevention and detection of oral diseases, today introduced an angled exam mirror as part of the ViziLite(R) Plus oral lesion identification and marking system. The autoclavable mirror attaches to the top of the ViziLite Plus lightstick retractor, enhancing dental professionals' ability to see oral lesions during a comprehensive oral cancer screening procedure.
"Early diagnosis is essential for improving the oral cancer survival rate," said Dr. Nelson Rhodus, Professor at the University of Minnesota School of Dentistry. "Using an oral cancer screening tool, such as ViziLite Plus, greatly increases the ability to confirm the presence of cancerous lesions, and improve treatment outcomes for patients."
Statistics from SEER data and the Oral Cancer Foundation show that approximately 100 people in the United States are diagnosed with oral cancer every day(1, 2). Seventy percent of these cases will be diagnosed at a late stage, which partially accounts for the poor five-year survival rate of only 60 percent(3).
"Most of the progress which has been made in the survival rates of all cancers has been through early detection," said Steve Garrett, D.D.S., Vice President - Clinical Development for TOLMAR, parent company of Zila. "Oral cancer should not hold the high position it does as a killer. When it is caught early, it is 80 to 90 percent curable."
In the U.S., oral cancer accounts for approximately three percent of all cancers but survival rates are among the lowest of major cancers(4). Approximately 9,000 deaths occur from oral cancer each year, making it more deadly than breast cancer, cervical cancer and prostate cancer(4).
With the release of the new angled exam mirror, Zila hopes to not only improve the rate of early detection of oral lesions, but also to underscore the importance of annual oral cancer screenings, especially for at-risk patients. Ninety-five percent of oral cancers occur in patients 40 and older, with those at highest risk being smokers and chronic alcohol consumers age 65 and older(5, 6). Research from Johns Hopkins and other institutions suggests that the human papilloma virus (HPV), best known as the primary cause of cervical cancer, may also cause certain types of oral cancer(7).
Screening for oral cancer is a simple non-invasive procedure that can be performed quickly and at minimal cost to the patient; it is often covered by dental insurance.
Zila, a TOLMAR company, provides a combined range of high-quality products surrounding consumable home care products, in-office diagnostics, acute care products and prevention tools that allow dental professionals to effectively treat their patients to the highest professional standards.
1. Oral Cancer Foundation web site. Oral cancer facts. Accessed June 1, 2010. Available at: http://oralcancerfoundation.org/facts/index.htm.
2. National Cancer Institute. SEER web site. SEER stat fact sheets: oral cavity and pharynx. Accessed June 1, 2010. Available at: http://seer.cancer.gov/statfacts/html/oralcav.html.
3. American Cancer Society. Oral Cancer. Accessed April 14, 2010. Available at: http://www.cancer.org/docroot/PRO/content/PRO_1_1x_Oral_Cancer.pdf.asp?sitearea=PRO.
4. Messadi DV, Wilder-Smith P, Wolinsky L. Improving oral cancer survival: the role of dental providers. J Calif Dent Assoc. 2009;37(11):789-798.
5. Epstein JB, Silverman S, Epstein JD, et al. Analysis of oral lesion biopsies identified and evaluated by visual examination, chemiluminescence and toluidine blue. Oral Oncol. 2007;44(6):538-544.
6. Rhodus NL. Oral cancer and precancer: improving outcomes. Compendium. 2009;30(8):2-15.
7. Hennessey PT, Westra WH, Califano JA. Human papillomavirus and head and neck squamous cell carcinoma: recent evidence and clinical implications. J Dent Res. 2009;88(4):300-306.